NLRP3 and focal segmental glomerulosclerosis: Moreover, by showing that in aged mice with experimental FSGS, injury augments the age-dependent increase of NLRP3 signaling, it makes this pathway an intriguing therapeutic target for podocyte diseases in the elderly.